Newsroom

Featured

Mark Levick appointed CEO of Alvotech

Alvotech today announced the appointment of Mark Levick as Chief Executive Officer, effective 5 August 2019. Mark brings over 18 years of global industry experience, with a very impressive track record of value creation and success in bringing new biosimilars to market. Prior to joining Alvotech, Mark was the head of development of Sandoz biopharmaceuticals. He succeeds Rasmus Rojkjaer, who has stepped down from his role.

Read More
MEET THE MANAGEMENT

Highly experienced management team with a proven track record of achieving high...

Media Gallery

Download center for company logos and images.

News alert

Enter your email to sign up for news alerts

MEDIA CONTACT

Halldor Kristmannsson 
Vice President
Organizational Development
Global Communications & Branding

Phone (354) 522-2900

Email
Connect on LinkedIn

We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. Learn more.